Long-term results of Nivolumab + Cabozantinib in RCC

Published Date: 08 Mar 2023

The combination of first-line nivolumab and cabozantinib continues to outperform sunitinib in the treatment of patients with advanced renal cell carcinoma (RCC).

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Ketamine plus psychotherapy for "excellent" PTSD

2.

Utilizing cerium/lanthanum-134 to improve cancer detection and treatment.

3.

Having a tattoo could increase your risk of developing lymphoma.

4.

New study reveals racial disparities in breast cancer diagnosis and outcomes in Canada

5.

Males with early-onset colorectal cancer are at risk, according to a study.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot